New drug cocktail offers hope for head and neck cancer patients who failed immunotherapy
NCT ID NCT06725368
First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 16 times
Summary
This study is for adults with advanced head and neck cancer that has returned or spread and no longer responds to standard first-line immunotherapy (pembrolizumab) with or without chemotherapy. Researchers want to see if a combination of three drugs—carboplatin, paclitaxel, and cetuximab—can shrink tumors or slow the disease. The trial will enroll 46 participants in France and follow them for 12 months, tracking tumor response, side effects, and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Besançon
RECRUITINGBesançon, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Hospitalier de Colmar
RECRUITINGColmar, 68024, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre Paul Strauss
RECRUITINGStrasbourg, 67033, France
Contact Email: •••••@•••••
Contact
Contact
Contact
-
Centre hospitalier Régional de Metz-Thionville
RECRUITINGArs-Laquenexy, 57085, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institut de cancérologie de Lorraine
RECRUITINGVandœuvre-lès-Nancy, 54519, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.